Strong Industry Presence Icosagen has established itself as a reputable European CRDMO with over 25 years of experience and a strong client base of more than 100 biotech and pharma companies managing 500+ projects, indicating substantial opportunities for collaborations in complex protein and antibody development.

Innovative Expansion Recent investments in a state-of-the-art cGMP production facility and acquisitions like Carterra enhance Icosagen's capabilities in antibody discovery and manufacturing, presenting opportunities to sell advanced bioprocessing equipment, reagents, and contract services tailored to high-tech production needs.

Recognition & Awards Winning national awards for innovation and business excellence underlines Icosagen’s commitment to industry leadership, making it a strategic partner for cutting-edge biotechnological solutions and enabling sales pitches centered on innovation-driven products and services.

Research & Development Focus Investment into developing novel platforms for mammalian cell line development and launching CE-IVD products indicate ongoing R&D activities, creating opportunities to provide supporting technologies, diagnostic tools, or R&D collaboration offerings to accelerate their development pipeline.

Growth & Investment With significant funding and a multi-million euro investment in expanding capabilities, Icosagen is positioned for further growth, offering potential sales opportunities in laboratory equipment, manufacturing technology, and supply chain solutions to support their scaled-up production and research activities.